These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18654297)

  • 1. The need for rules and regulations.
    Helmus MN
    Nat Nanotechnol; 2007 Jun; 2(6):333-4. PubMed ID: 18654297
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulating nanomedicine.
    Nat Mater; 2007 Apr; 6(4):249. PubMed ID: 17401411
    [No Abstract]   [Full Text] [Related]  

  • 3. Exploring emerging nanobiotechnology drugs and medical devices.
    Paradise J; Diliberto GM; Tisdale AW; Kokkoli E
    Food Drug Law J; 2008; 63(2):407-20. PubMed ID: 18561467
    [No Abstract]   [Full Text] [Related]  

  • 4. They are from the government and they really are here to help you.
    Woosley RL
    J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
    [No Abstract]   [Full Text] [Related]  

  • 5. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA perspectives on supplement use by patients on antithrombotic therapy.
    Kim MJ
    Thromb Res; 2005; 117(1-2):197-200; discussion 201-7. PubMed ID: 16188297
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.
    Woo JJ
    Thromb Res; 2005; 117(1-2):193-6; discussion 201-7. PubMed ID: 16253311
    [No Abstract]   [Full Text] [Related]  

  • 8. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 9. 'New' FDA delivers in 2003.
    Schmidt E; Wong R
    Nat Rev Drug Discov; 2003 Dec; 2(12):941-2. PubMed ID: 14756139
    [No Abstract]   [Full Text] [Related]  

  • 10. Scientific and legal viability of follow-on protein drugs.
    Dudzinski DM; Kesselheim AS
    N Engl J Med; 2008 Feb; 358(8):843-9. PubMed ID: 18287608
    [No Abstract]   [Full Text] [Related]  

  • 11. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering?
    Purnhagen KP
    Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663
    [No Abstract]   [Full Text] [Related]  

  • 12. Is special FDA regulation of nanomedicine needed? A conversation with Norris E. Alderson. Interview by Barbara J Culliton.
    Alderson NE
    Health Aff (Millwood); 2008; 27(4):w315-7. PubMed ID: 18559355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. US court rules to allow experimental drugs for dying patients.
    Waltz E
    Nat Med; 2006 Jun; 12(6):596. PubMed ID: 16760988
    [No Abstract]   [Full Text] [Related]  

  • 14. The 21 CFR (Code of Federal Regulations) online database: Food and Drug Administration regulations full-text.
    Bobka MS
    Med Ref Serv Q; 1993; 12(1):7-15. PubMed ID: 10126251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA to steer nanotech.
    Fox JL
    Nat Biotechnol; 2008 Oct; 26(10):1060. PubMed ID: 18846060
    [No Abstract]   [Full Text] [Related]  

  • 16. Bush tails follow-ons.
    Fox J
    Nat Biotechnol; 2008 Apr; 26(4):366. PubMed ID: 18392007
    [No Abstract]   [Full Text] [Related]  

  • 17. Democrats prioritize pricing, generics and drug safety.
    Fox JL
    Nat Biotechnol; 2007 Feb; 25(2):150-1. PubMed ID: 17287735
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes to US drug safety laws take center stage.
    Wadman M
    Nat Med; 2007 Apr; 13(4):389. PubMed ID: 17415357
    [No Abstract]   [Full Text] [Related]  

  • 19. The Food and Drug Administration's regulation of dental products.
    Pinco RG; Rubin PD
    J Clin Dent; 1995; 6(3):165-9. PubMed ID: 8615957
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA-VMAC calls for increased regulation of new antimicrobials; animal groups question conclusion.
    Nolen S
    J Am Vet Med Assoc; 1999 Mar; 214(6):767, 772. PubMed ID: 10101403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.